Georgia Cancer Center at Augusta University ( Site 0222) — Augusta, Georgia

Georgia Cancer Center at Augusta University ( Site 0222) is a clinical research site located in Augusta, Georgia, United States 30912.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Georgia Cancer Center at Augusta University ( Site 0222) has participated in 1 clinical trials.

Therapeutic areas: Endometrial Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgia Cancer Center at Augusta University ( Site 0222)?

Georgia Cancer Center at Augusta University ( Site 0222) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgia Cancer Center at Augusta University ( Site 0222) conducted?

Georgia Cancer Center at Augusta University ( Site 0222) has 1 clinical trials on record. Their work covers Endometrial Neoplasms.

Is Georgia Cancer Center at Augusta University ( Site 0222) accredited by Crixeo Health?

Georgia Cancer Center at Augusta University ( Site 0222) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgia Cancer Center at Augusta University ( Site 0222)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.